DIRECT BIOLOGICS
Direct Biologics is an incubation center that manufactures science-based regenerative biological products.
DIRECT BIOLOGICS
Industry:
Biotechnology Manufacturing Pharmaceutical Product Research
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.directbiologics.com
Total Employee:
11+
Status:
Active
Contact:
800-791-1021
Email Addresses:
[email protected]
Similar Organizations
Getein Biotech
Getein Biotech manufactures medical products.
iBio Connect
iBio Connect is a provider of life science research products.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Viscus Biologics
Viscus Biologics is a manufacture company that provides market innovative biologic products and Medical Device.
Official Site Inspections
http://www.directbiologics.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Direct Biologics"
Company | Direct Biologics
Direct Biologics is a pioneering leader and cGMP manufacturer of regenerative biologic products, driven by science and innovation. Our company is dedicated to delivering cutting-edge clinical …See details»
Direct Biologics - Crunchbase Company Profile
Direct Biologics is a market leading innovator and cGMP manufacturer of regenerative biologic products, including ExoFlo. View contacts for Direct Biologics to access new leads and connect with decision-makers.See details»
Investors | Direct Biologics
Apr 26, 2023 Direct Biologics is a pioneering leader and cGMP manufacturer of regenerative biologic products, driven by science and innovation. Our company is dedicated to delivering …See details»
Direct Biologics - PitchBook
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Information on valuation, funding, acquisitions, investors, and executives for Direct Biologics. …See details»
Direct Biologics - LinkedIn
Direct Biologics is a market-leading innovator in regenerative medicine. If you are an adult with Crohn’s disease (CD), you may be eligible for the ExoFlo study evaluating the safety and efficacy of an investigational cell derived therapeutic …See details»
Direct Biologics to list in U.S. via $1 billion SPAC | Reuters
Oct 13, 2022 Regenerative products manufacturer Direct Biologics plans to list in the United States by merging with blank-check firm Good Works II Acquisition Corp in a deal valued at …See details»
FDA Approves Direct Biologics to Proceed with a ... - Markets Insider
AUSTIN, Texas, April 21, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced …See details»
Contact - Direct Biologics
Direct Biologics is a science-based market leading innovator and certified cGMP manufacturer of regenerative biologic products.See details»
Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 …
Apr 6, 2022 For more information on Direct Biologics and regenerative medicine, visit: https://directbiologics.com. About Direct Biologics Direct Biologics, LLC, is headquartered in …See details»
Direct Biologics Announces First Patient Treated Under Phase II ...
AUSTIN, Texas - December 30, 2020 - ( Newswire.com ) Direct Biologics, LLC, announced today that the first patient has been treated under its expanded access protocol for ExoFlo Infusion …See details»
Direct Biologics Announces FDA Acceptance of IND Application …
Jul 14, 2021 Direct Biologics is dedicated to pursuing additional clinical applications of ExoFlo through the FDA's investigational new drug application process. For more information, visit …See details»
Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a ...
Apr 26, 2023 Direct Biologics 800-791-1021 [email protected] Twitter: @directbiologics Investor Relations LHA Investor Relations Yvonne Briggs 310-691-7100 [email protected] …See details»
Patients - Direct Biologics
Direct Biologics is a science-based market leading innovator and certified cGMP manufacturer of regenerative biologic products.See details»
FDA Approves Direct Biologics to Proceed with a Landmark
Apr 26, 2022 For more information on Direct Biologics and regenerative medicine, visit directbiologics.com. SOURCE Direct Biologics Katherine Collins, [email protected] , 361-563 …See details»
Direct Biologics Reports Compelling Results From Phase 2 Trial …
Mar 14, 2023 Direct Biologics, LLC 800-791-1021 [email protected] Twitter: @directbiologics Investor Relations LHA Investor Relations Yvonne Briggs 310-691-7100 …See details»
Direct Biologics Granted Expanded Access by FDA for ExoFlo™ in …
AUSTIN, Texas, Oct. 13, 2020 /PRNewswire/ -- Direct Biologics, LLC, announced today that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 …See details»
Technology | Direct Biologics
[email protected]. Mailing Address. Direct Biologics 5301 Southwest Parkway Building 1, Suite 415 Austin, Texas 78735, US. Phone Number (800) 791-1021See details»
Pipeline | Direct Biologics
[email protected]. Mailing Address. Direct Biologics 5301 Southwest Parkway Building 1, Suite 415 Austin, Texas 78735, US. Phone Number (800) 791-1021See details»
FDA Approves Direct Biologics to Proceed with a Landmark Phase …
AUSTIN, Texas, April 26, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced …See details»